Corrigendum to: Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness (EMBO reports, (2016), 17, 11, (1609-1623), 10.15252/embr.201642352)

Vijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, Simon J. Baumgart, Andreas Mund, Marian Grade, Hüseyin Sirma, Ronald Simon, Hans Will, Matthias Dobbelstein, Ekkehard Dikomey, Steven Johnsen

Research output: Contribution to journalComment/debate

Abstract

The authors contacted EMBO reports in May 2017 to correct one figure. Routine image analysis by the journal uncovered further inconsistencies. Following further analysis, the journal has agreed to correct the following panels and legends. (Figure Presented.).

Original languageEnglish (US)
Article numbere46783
JournalEMBO Reports
Volume19
Issue number10
DOIs
StatePublished - Oct 1 2018
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Kari, V., Mansour, W. Y., Raul, S. K., Baumgart, S. J., Mund, A., Grade, M., Sirma, H., Simon, R., Will, H., Dobbelstein, M., Dikomey, E., & Johnsen, S. (2018). Corrigendum to: Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness (EMBO reports, (2016), 17, 11, (1609-1623), 10.15252/embr.201642352). EMBO Reports, 19(10), [e46783]. https://doi.org/10.15252/embr.201846783